Skip to content
← Back to this collection

PUBLICATIONS · 32641156

High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Acta Neuropathol Commun
Publication date
2020 Jul 8
First author
Raffeld M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Raffeld M
      type
      Author
    2. name
      Abdullaev Z
      type
      Author
    3. name
      Pack SD
      type
      Author
    4. name
      Xi L
      type
      Author
    5. name
      Nagaraj S
      type
      Author
    6. name
      Briceno N
      type
      Author
    7. name
      Vera E
      type
      Author
    8. name
      Pittaluga S
      type
      Author
    9. name
      Lopes Abath Neto O
      type
      Author
    10. name
      Quezado M
      type
      Author
    11. name
      Aldape K
      type
      Author
    12. name
      Armstrong TS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Raffeld M
      type
      Author
    2. name
      Abdullaev Z
      type
      Author
    3. name
      Pack SD
      type
      Author
    4. name
      Xi L
      type
      Author
    5. name
      Nagaraj S
      type
      Author
    6. name
      Briceno N
      type
      Author
    7. name
      Vera E
      type
      Author
    8. name
      Pittaluga S
      type
      Author
    9. name
      Lopes Abath Neto O
      type
      Author
    10. name
      Quezado M
      type
      Author
    11. name
      Aldape K
      type
      Author
    12. name
      Armstrong TS
      type
      Author
    bibliography ids
    1. nci-bib-aae66a96acf900c879daa7de
    book metadata
    content sha256
    40dd01407d40ca696d5ecb96ec84dd04319ec80a577e362b924f1c0010de33ba
    document type
    citation
    dois
    1. 10.1186/s40478-020-00973-y
    electronic publication date
    display
    2020 Jul 8
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32641156
    immutable id
    pubmed:32641156@40dd01407d40ca696d5ecb96ec84dd04319ec80a577e362b924f1c0010de33ba
    journal
    abbreviation
    Acta Neuropathol Commun
    issn electronic
    2051-5960
    issn print
    Source null
    issue
    1
    name
    Acta neuropathologica communications
    nlm unique id
    101610673
    pages
    101
    volume
    8
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32641156
      provenance
      batch id
      40d9eae1f1d369f13109
      provider
      NCBI PubMed ESummary
      record sha256
      77b827e6cceecc0460de02f61480081a30b9b5d861611fd7c3b83dd6b9f73536
      response sha256
      03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
      retrieved at
      2026-09-09T23:47:52.637547+00:00
      publication date
      display
      2020 Jul 8
      precision
      day
      year
      2020
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Intramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32641156/
      title
      High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice